氘代新药,达成一项授权

药事纵横
Aug 30

注:本文不构成任何投资意见和建议,以官方/公司公告为准;本文仅作医疗健康相关药物介绍,非治疗方案推荐(若涉及),不代表平台立场。任何文章转载需得到授权。药融圈获悉:近期,汇宇制药(688553.SH)公告称,全资子公司汇辰昕拟与同源康签署《关于同源康“TY-9591”产品的全国总代理协议》,同源康同意将其“TY-9591”产品的全国总代理权授权给汇辰昕,里程碑首付款为15,000万元人民币。“TY...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10